GlassScriptPhysician profile
Kyle Phillip Quillin
NPI 1568824027
$883.09
in general payments reported to CMS, 2019-2025
16 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.37 · 2021: $147 · 2022: $73.11 · 2023: $187 · 2024: $158 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.86 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $207.39 | 2022-2024 | Stealthstation S8 Platform, Sinuva |
| Davol INC. | $135.36 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $117.92 | 2023-2025 | Dupixent |
| Genzyme Corporation | $87.53 | 2024-2025 | |
| Medtronic USA, INC. | $69.74 | 2019 | |
| Aerin Medical INC. | $51.81 | 2021-2024 | |
| Optinose US, INC. | $35.20 | 2025 | |
| Stryker Corporation | $30.80 | 2022-2024 | Scopis Ent |
| Abbvie INC. | $29.48 | 2025 | |
| Heartflow, INC. | $19.96 | 2025 | |
| Sanofi Pasteur INC. | $19.40 | 2023 | |
| Abbott Laboratories | $19.08 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Lundbeck LLC | $18.54 | 2025 | Vyepti |
| Vertex Pharmaceuticals Incorporated | $13.81 | 2025 | |
| Cochlear Americas | $13.63 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greer Laboratories, INC. | $13.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Quillin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.